Prion protein (PrP) is not involved in the pathogenesis of spongiform encephalopathy in transgenic mice expressing interleukin-6 in the brain

Neuroscience Letters

Volumn 234, Issue 1, 1997, Pages 15-18

  Castelnau, Pierre A ^a,b   Campbell, Iain L ^b   Powell, Henry C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Blood brain barrier; Cytokine; Degeneration; Glia; Prion protein; Spongiosis; Swelling; Transgenic

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN SPONGIOSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BRAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOBLOTTING; INTERLEUKIN-6; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; PRION DISEASES; PRIONS;

EID: 0030865330     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00670-8     Document Type: Article

References (21)

1. Adornato B., Lampert P. Status spongiosus of nervous tissue. Acta Neuropathol. 19:1971;271-289.
2. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 379:1996;339-343.
3. Brett F.M., Mizisin A.P., Powell H.C., Campbell I.L. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. 54:1995;766-775.
4. Brown D.R., Schmidt B., Kretzschmar H.A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 380:1996;345-347.
5. Campbell I.L., Abraham C.A., Masliah E., Kemper P., Inglis J.D., Oldstone M.B.A., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc. Natl. Acad. Sci. USA. 90:1993;10061-10065.
6. Campbell I.L., Eddleston M., Kemper P., Oldstone M.B.A., Hobbs M.V. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68:1994;2383-2387.
7. Campbell I.L., Powell H.C. Role of cytokines in demyelinating disease studied in transgenic mice. Methods: A companion to Methods Enzymol. 10:1996;462-477.
8. Chiang C.-S., Stalder A., Samimi A., Campbell I.L. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16:1994;212-221.
9. DeArmond S.J., Mobley W.C., DeMott D.L., Barry R.A., Beckstead J.H., Prusiner S.B. Changes in the localization of brain prion proteins during scrapie infection. Neurology. 37:1987;1271-1280.
10. Heyser C.J., Masliah E., Samimi A., Campbell I., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin-6 in the brain. Proc. Natl. Acad. Sci. USA. 94:1997;1500-1505.
11. Kimelberg H.K. Current concepts of brain oedema: review of laboratory investigations. J. Neurosurg. 83:1995;1051-1059.
12. Kishimoto T., Shizuo A., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 258:1992;593-597.
13. Kordek R., Nerurkar V.R., Liberski P.P., Isaacson S., Yanagihara R., Gajdusek D.C. Heightened expression of tumor necrosis factor a, interleukin 1a, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. USA. 93:1996;9754-9758.
14. Lasmezas C., Deslys J.P., Dormont D. Recombinant human growth hormone and insulin-like growth factor 1 induce PrP gene expression in PC12 cells. Biochem. Biophys. Res. Commun. 196:1993;1163-1169.
15. Lazarini F., Castelnau P., Chermann J.F., Deslys J.P., Dormont D. Modulation of prion protein gene expression by growth factors in cultured mouse astrocytes and PC-12 cells. Mol. Brain Res. 22:1994;268-274.
16. Lotz M. Interleukin-6: a comprehensive review. Cancer Treat. Res. 80:1995;209-233.
17. Mobley W.C., Neve R.L., Prusiner S.B., McKinley M.P. Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. USA. 85:1988;9811-9815.
18. Norenberg M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53:1994;213-220.
19. Prusiner, S.B., Prions. In B.N. Fields, D.M. Knipe and P.M. Howley (Eds.), Fundamental Virology, Lippincott-Raven, Philadelphia, PA, 1996, pp. 1245-1294.
20. Westaway D., DeArmond S.J., Cayetano-Canlas J., Groth D., Foster D., Yang S.-L., Torchia M., Carlson G.A., Prusiner S.B. Degeneration of skeletal muscle, peripheral nerves and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 76:1994;117-129.
21. Wion D., Bert M.L., Brachet P. mRNAs of β-amyloid precursor protein and PrP are regulated by nerve growth factor in PC-12 cells. Int. J. Dev. Neurosci. 64:1988;387-393.